Sands Capital Management’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,189,421
Closed -$79.3M 74
2022
Q1
$79.3M Sell
4,189,421
-43,916
-1% -$1.12M 0.18% 56
2021
Q4
$149M Buy
4,233,337
+43,884
+1% +$1.43M 0.28% 47
2021
Q3
$153M Buy
4,189,453
+100,982
+2% +$3.97M 0.26% 47
2021
Q2
$161M Buy
4,088,471
+89,872
+2% +$2.6M 0.27% 54
2021
Q1
$113M Buy
3,998,599
+472,641
+13% +$15.1M 0.22% 55
2020
Q4
$113M Buy
3,525,958
+253,924
+8% +$7.81M 0.21% 58
2020
Q3
$106M Buy
3,272,034
+770,058
+31% +$24M 0.23% 55
2020
Q2
$69M Buy
2,501,976
+130,051
+5% +$2.82M 0.17% 56
2020
Q1
$42.3M Buy
2,371,925
+865,350
+57% +$20.9M 0.14% 60
2019
Q4
$37.8M Buy
1,506,575
+610,205
+68% +$13.4M 0.11% 62
2019
Q3
$16M Buy
896,370
+28,497
+3% +$593K 0.05% 70
2019
Q2
$19.1M Buy
867,873
+50,882
+6% +$1.45M 0.06% 66
2019
Q1
$25M Sell
816,991
-13,529
-2% -$337K 0.08% 52
2018
Q4
$19.2M Buy
830,520
+322,245
+63% +$10M 0.07% 52
2018
Q3
$16.4M Buy
+508,275
New +$15.5M 0.05% 50

Other funds holding HCM

Sands Capital Management's HCM Position: Q2 2022 in Review

Sands Capital Management sold out of HUTCHMED (HCM) in Q2 2022, closing a stake of 4,189,421 shares — an estimated $79.3M sold.

Sands Capital Management first reported a position in HCM in Q3 2018 and held it in 15 quarters. The position peaked at $161M in Q2 2021. 116 funds tracked by Wall St. Rank hold HCM as of Q2 2022.

  • Sands Capital Management reported no remaining HUTCHMED position as of Q2 2022 after selling out during the quarter.
  • Sands Capital Management sold 4,189,421 HUTCHMED shares in Q2 2022, an estimated $79.3M.
  • Sands Capital Management first reported a position in HUTCHMED in Q3 2018 and held it in 15 quarters.
  • Sands Capital Management's HUTCHMED position peaked at $161M in Q2 2021.
  • 116 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2022.

Based on Sands Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.